Chemours Works with Authorities in Northern China to Shutdown Chemical Plant Producing Fake Viton™ FreeFlow
18 Décembre 2023 - 12:45PM
Business Wire
Law enforcement agencies in northern China have shut down
large-scale manufacturing of counterfeit Viton™ FreeFlow™
fluoroelastomer, a product falsely bearing Chemours' trademarks, at
a local chemical plant.
During an investigation at the facility, authorities discovered
a substantial quantity of the fake fluoroelastomer, including 4.7
tons of finished products and 9 tons of raw materials (expected to
produce approximately 20 tons of finished products), as well as
packaging materials and related business documents. The value of
the counterfeit products was reported to be in the millions of
dollars.
The plant and its affiliated entities reportedly purchased
genuine Viton™ FreeFlow™ fluoroelastomer from Chemours local
subsidiaries to help mask their counterfeiting operations.
Local police, in collaboration with Chemours’ local counsel and
a subsidiary, have so far apprehended two individuals who now face
charges related to the illegal production and distribution of
counterfeit goods. The suspects' identities are being withheld
pending further investigation.
“This operation represents a significant stride in our ongoing
battle against counterfeit production and the illicit trade of fake
goods,” said Eric von Brockdorff, Global Product & Business
Director for Chemours. “Counterfeit goods, especially in the
chemical sector, pose substantial risks to safety, product quality,
and the reputation of authentic products.”
“The success of this interdiction also underscores the
importance of our collaborative efforts with law enforcement
agencies in combating counterfeit production,” von Brockdorff
added. “It’s yet another way we put the interests of our customers
and business partners first.”
About The Chemours Company The Chemours Company (NYSE:
CC) is a global leader in Titanium Technologies, Thermal &
Specialized Solutions, and Advanced Performance Materials providing
its customers with solutions in a wide range of industries with
market-defining products, application expertise and chemistry-based
innovations. We deliver customized solutions with a wide range of
industrial and specialty chemicals products for markets, including
coatings, plastics, refrigeration and air conditioning,
transportation, semiconductor and consumer electronics, general
industrial, and oil and gas. Our flagship products are sold under
prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™,
Viton™, Nafion™, and Krytox™. The company has approximately 6,600
employees and 29 manufacturing sites serving approximately 2,900
customers in approximately 120 countries. Chemours is headquartered
in Wilmington, Delaware and is listed on the NYSE under the symbol
CC.
For more information, we invite you to visit chemours.com or
follow us on Twitter @Chemours or LinkedIn.
Forward-Looking Statements This press release contains
forward-looking statements, within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, which involve risks and uncertainties.
Forward-looking statements provide current expectations of future
events based on certain assumptions and include any statement that
does not directly relate to a historical or current fact. The words
"believe," "expect," "will," "anticipate," "plan," "estimate,"
"target," "project" and similar expressions, among others,
generally identify "forward-looking statements," which speak only
as of the date such statements were made. These forward-looking
statements may address, among other things, the outcome or
resolution of any pending or future environmental liabilities, the
commencement, outcome or resolution of any regulatory inquiry,
investigation or proceeding, the initiation, outcome or settlement
of any litigation, changes in environmental regulations in the U.S.
or other jurisdictions that affect demand for or adoption of our
products, anticipated future operating and financial performance
for our segments individually and our company as a whole, business
plans, prospects, targets, goals and commitments, capital
investments and projects and target capital expenditures, plans for
dividends or share repurchases, sufficiency or longevity of
intellectual property protection, cost reductions or savings
targets, plans to increase profitability and growth, our ability to
make acquisitions, integrate acquired businesses or assets into our
operations, and achieve anticipated synergies or cost savings, all
of which are subject to substantial risks and uncertainties that
could cause actual results to differ materially from those
expressed or implied by such statements. Forward-looking statements
are based on certain assumptions and expectations of future events
that may not be accurate or realized, such as full year guidance
relying on models based upon management assumptions regarding
future events that are inherently uncertain. These statements are
not guarantees of future performance. Forward-looking statements
also involve risks and uncertainties that are beyond Chemours'
control. Matters outside our control, including general economic
conditions and the COVID-19 pandemic, have affected or may affect
our business and operations and may or may continue to hinder our
ability to provide goods and services to customers, cause
disruptions in our supply chains such as through strikes, labor
disruptions or other events, adversely affect our business
partners, significantly reduce the demand for our products,
adversely affect the health and welfare of our personnel or cause
other unpredictable events. Additionally, there may be other risks
and uncertainties that Chemours is unable to identify at this time
or that Chemours does not currently expect to have a material
impact on its business. Factors that could cause or contribute to
these differences include the risks, uncertainties and other
factors discussed in our filings with the U.S. Securities and
Exchange Commission, including in our Quarterly Report on Form 10-Q
for the quarter ended September 30, 2023 and in our Annual Report
on Form 10-K for the year ended December 31, 2022. Chemours assumes
no obligation to revise or update any forward-looking statement for
any reason, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231218536474/en/
INVESTORS Brandon Ontjes VP, Financial Planning &
Analysis and Investor Relations +1.302.773.3300
investor@chemours.com
Kurt Bonner Manager, Investor Relations +1.302.773.0026
investor@chemours.com
NEWS MEDIA Cassie Olszewski Corporate Media & Brand
Reputation Leader +1.302.219.7140 media@chemours.com
Chemours (NYSE:CC)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Chemours (NYSE:CC)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024